Advances In The Cancer Genome Analysis Of Challenging Cancer Cases

Monday Lunch Livestream

With Professor Sean Grimmond

25 October 2021

Over the last decade, genomics has revolutionised our ability to discern the root-cause of malignant cancer and identify its potential therapeutic vulnerabilities, resulting in groundbreaking treatments to fight cancer.

Hear Professor Sean Grimmond, Director of the University of Melbourne Centre for Cancer Research, in this special presentation, review how the latest international cancer efforts have provided new foundations for improved cancer-diagnostic tools.

Professor Grimmond discusses how these comprehensive whole genome diagnostic approaches are being tested in challenging cancer cases.

Professor Sean Grimmond

Professor Sean Grimmond is Director of the University of Melbourne Centre for Cancer Research, Head of Melbourne Medical School’s Department of Clinical Pathology and is the Bertalli Chair in Cancer Medicine. Sean is the co-chair of the VCCC Precision Oncology program and leads the UMCCRs Cancers of Low Survival & Unmet Need Initiative (COLUMN).

Professor Grimmond holds a Genetics PhD (UQ), is a Scientific Fellow (RCPA) and a Fellow of the Australian Academy of Health and Medical Sciences. Professor Grimmond pioneered patient genome and transcriptome almost a decade ago and led Australia’s International Cancer Genome Consortium efforts, which identified the mutagenic processes, driver mutations, and therapeutic vulnerabilities of many high-mortality malignancies.